Abstract:Background Glycated albumin is the predominant circulating Amadori-type glycated protein in vivo and plays a major role in the development of diabetic vascular complications. The aim of this study was to assess the relationship between increased serum glycated albumin level and the presence and severity of coronary artery disease (CAD) in patients with type 2 diabetes mellitus (T2DM).Methods and Results In a total of 320 consecutive patients with T2DM, coronary angiography revealed normal coronary arteries in 83 patients (control group) and significant coronary stenosis (>= 70% luminal diameter narrowing) in 237, of whom 51 patients had 1-vessel disease (Group I), 80 had 2-vessel disease (Group II), and 106 had 3-vessel disease (Group III). Serum glycated albumin, hemoglobin Alc (HbAlc) and tumor necrosis factor (TNF)-alpha levels, lipid profile, and renal function were measured. Logistic regression analysis was performed to determine the relative risk of serum glycated albumin level for the presence and severity of CAD. Multivariate stepwise linear regression analysis was done to identify independent determinants of the glycated albumin level. Serum glycated albumin (21.2 +/- 5.3% vs 19.4 +/- 4.3%, p=0.005) and TNF-alpha levels (123 +/- 115 pg/ml vs 65 +/- 59 pg/ml, p < 0.001) were significantly higher in patients with CAD than in controls, but serum HbAlc level did not significantly differ between them (7.6 +/- 1.3% vs 7.4 +/- 1.2%, p=0.19). There was a significant difference in serum glycated albumin level between Groups I and III (19.5 +/- 3.3% vs 21.8 +/- 5.7%, p < 0.001). The serum glycated albumin level correlated with the number of diseased arteries (Spearman r=0.205, p < 0.001), and was closely related to serum levels on admission of glucose (r=0.495, p < 0.001), TNF-alpha (r=0.123, p=0.028), blood urea nitrogen (r=0.167, p=0.004), triglycerides (r=0.129, p=0.021), and HbAlc (r=0.795, p < 0.001). Multivariate analysis indicated that serum levels of glucose (p < 0.0001), TNF-alpha (p=0.001), blood urea nitrogen (p=0.004) and triglycerides (p=0.035) were independent determinants for glycated albumin. Logistic regression analysis revealed that glycated albumin >= 19% (odds ratio (OR) 2.9, p < 0.001) was an independent predictor for CAD and glycated albumin >= 21% (OR 2.3, p=0.032) for 3-vessel disease prediction. The area under the receiver-operating characteristic curve for glycated albumin (0.620, 95% confidence interval (CI) 0.548 to 0.691, p=0.001) was superior to that for HbAlc (0.543, 95% CI 0.473 to 0.613, p=0.243).Conclusions An increased serum level of glycated albumin is associated with the presence and severity of CAD, and may be useful in screening patients with T2DM.

The clinical impact of serum 1,5-anhydro-D-glucitol levels on coronary artery calcification and adverse outcomes assessed by coronary optical coherence tomography in diabetic patients

ELEVATION OF HEMOGLOBIN A1C INCREASE THE ATHEROSCLEROTIC PLAQUE VULNERABILITY AND THE VISIT-TO-VISIT VARIABILITY OF LIPID PROFILES IN PATIENTS WHO UNDERWENT ELECTIVE PERCUTANEOUS CORONARY INTERVENTION

Nonlinear Association of 1,5-Anhydroglucitol with the Prevalence and Severity of Coronary Artery Disease in Chinese Patients Undergoing Coronary Angiography

Prognostic Value of Serum 1,5-anhydroglucitol Levels in Patients with Acute Myocardial Infarction

Impact of Glycemic Control on Coronary Inflammation Evaluated by Computed Tomography Pericoronary Fat Attenuation Index in Patients with Acute Coronary Syndrome

Low 1,5-anhydroglucitol levels are associated with long-term cardiac mortality in acute coronary syndrome patients with hemoglobin A1c levels less than 7.0

The Relationship Between Serum 1,5-Anhydroglucitol and Adverse Outcomes in Acute Coronary Syndrome with and Without Chronic Kidney Disease Patients

Coronary Angiographic Studies of Impaired Glucose Regulation and Coronary Artery Disease in Chinese Nondiabetic Subjects

Glycated Albumin is More Closely Correlated with Coronary Artery Disease Than 1,5-Anhydroglucitol and Glycated Hemoglobin A1c

Relationship Between 1,5-Anhydroglucitol and Renal Function Assessed by Dynamic Renal Scintigraphy in Type 2 Diabetes.

Oral Glucose Tolerance Tests and Serum Insulin Levels in Patients Suspected to Coronary Artery Disease and Its Clinical Significance

Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes

Serum Free Fatty Acids Are Associated with Severe Coronary Artery Calcification, Especially in Diabetes: a Retrospective Study

Serum 1,5-Anhydroglucitol when Used with Fasting Plasma Glucose Improves the Efficiency of Diabetes Screening in a Chinese Population

Serum Advanced Glycation End-Products and Receptors As Prognostic Biomarkers in Diabetics Undergoing Coronary Artery Stent Implantation

The progress of clinical research on the detection of 1,5-anhydroglucitol in diabetes and its complications

Analysis of Angiographic Patterns in Acute Coronary Syndrome Patients With Diabetes Mellitus: Correlation With HbA1c Levels

Elevated Glycated Albumin in Serum Is Associated with Adverse Cardiac Outcomes in Patients with Acute Coronary Syndrome Who Underwent Revascularization Therapy

Glucose Metabolism Status and Angiographic Features of Coronary Artery in Patients Undergoing Their First Coronary Angiography: Study of 553 Cases

Serum 1,5-anhydroglucitol levels slightly increase rather than decrease after a glucose load in subjects with different glucose tolerance status

Increased Serum Glycated Albumin Level Is Associated With The Presence And Severity Of Coronary Artery Disease In Type 2 Diabetic Patients